Michael Saylor says Strategy may sell Bitcoin if needed, as dividends, a $1.5B note buyback and liquidity questions test its treasury model.News, Bitcoin, StrategyRead More

You might also be interested in reading AbCellera Biologics GAAP EPS of -$0.12 beats by $0.04, revenue of $17.1M beats by $10.74M.